VFA
BDSI

Virtus Fund Advisers’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Virtus Fund Advisers’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,570
Closed -$43K – 2767
2014
Q2 		$43K Buy
+3,570
New +$33.8K ﹤0.01% 1983

Other funds holding BDSI

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Virtus Fund Advisers's BDSI Position: Q3 2014 in Review

Virtus Fund Advisers sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2014, closing a stake of 3,570 shares — an estimated $43K sold.

Virtus Fund Advisers first reported a position in BDSI in Q2 2014 and held it in 1 quarter. The position peaked at $43K in Q2 2014. 116 funds tracked by Wall St. Rank hold BDSI as of Q3 2014.

  • Virtus Fund Advisers reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 3,570 BioDelivery Sciences International, Inc. shares in Q3 2014, an estimated $43K.
  • Virtus Fund Advisers first reported a position in BioDelivery Sciences International, Inc. in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's BioDelivery Sciences International, Inc. position peaked at $43K in Q2 2014.
  • 116 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.